Answers are grounded in this paper and cite their sources.
Long-term sustained effectiveness of erenumab was reported only by a minority of resistant CM patients. Although more research in resistant migraine is needed, Erenumab can provide long-term meaningful reduction in migraine load and migraine-related disability in some patients.
No takes yet. Share an insight, caveat, or question.
Andreou et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: